Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
Kato A, Kobayashi K, Narukawa K, Minoshima Y, Adachi I, Hirono S, Nash RJ. Kato A, et al. Among authors: minoshima y. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5630-3. doi: 10.1016/j.bmcl.2010.08.038. Epub 2010 Aug 12. Bioorg Med Chem Lett. 2010. PMID: 20805028
Iminosugars from Baphia nitida Lodd.
Kato A, Kato N, Miyauchi S, Minoshima Y, Adachi I, Ikeda K, Asano N, Watson AA, Nash RJ. Kato A, et al. Among authors: minoshima y. Phytochemistry. 2008 Mar;69(5):1261-5. doi: 10.1016/j.phytochem.2007.11.018. Epub 2008 Jan 14. Phytochemistry. 2008. PMID: 18191969
Cytotoxic iridoid aldehydes from Taiwanese Viburnum luzonicum.
Fukuyama Y, Minoshima Y, Kishimoto Y, Chen IS, Takahashi H, Esumi T. Fukuyama Y, et al. Among authors: minoshima y. Chem Pharm Bull (Tokyo). 2005 Jan;53(1):125-7. doi: 10.1248/cpb.53.125. Chem Pharm Bull (Tokyo). 2005. PMID: 15635247 Free article.
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
Makker V, Taylor MH, Aghajanian C, Cohn AL, Brose MS, Simone CD, Cao ZA, Suttner L, Loboda A, Cristescu R, Jelinic P, Orlowski R, Dutta L, Matsui J, Dutcus CE, Minoshima Y, Messing MJ. Makker V, et al. Among authors: minoshima y. J Immunother Cancer. 2024 Jan 19;12(1):e007929. doi: 10.1136/jitc-2023-007929. J Immunother Cancer. 2024. PMID: 38242717 Free PMC article.
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors.
Kitano S, Fujiwara Y, Shimizu T, Iwasa S, Yonemori K, Kondo S, Shimomura A, Koyama T, Ebata T, Ikezawa H, Hayata N, Minoshima Y, Miura T, Kubota T, Yamamoto N. Kitano S, et al. Among authors: minoshima y. Cancer Chemother Pharmacol. 2022 Dec;90(6):523-529. doi: 10.1007/s00280-022-04480-w. Epub 2022 Oct 26. Cancer Chemother Pharmacol. 2022. PMID: 36289094 Clinical Trial.
49 results